These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28956332)

  • 21. Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.
    Clapcote SJ
    Adv Neurobiol; 2017; 17():103-131. PubMed ID: 28956331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations.
    Heckman PRA; Blokland A; Bollen EPP; Prickaerts J
    Neurosci Biobehav Rev; 2018 Apr; 87():233-254. PubMed ID: 29454746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.
    Zhang X; Feng Q; Cote RH
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3060-6. PubMed ID: 16123402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase inhibition in cognitive decline.
    García-Barroso C; Ugarte A; Martínez M; Rico AJ; Lanciego JL; Franco R; Oyarzabal J; Cuadrado-Tejedor M; García-Osta A
    J Alzheimers Dis; 2014; 42 Suppl 4():S561-73. PubMed ID: 25125473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells.
    Dragicevic N; Delic V; Cao C; Copes N; Lin X; Mamcarz M; Wang L; Arendash GW; Bradshaw PC
    Neuropharmacology; 2012 Dec; 63(8):1368-79. PubMed ID: 22959965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
    Osadchii OE
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer with phosphodiesterase inhibitors.
    Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
    Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T; Oka M; Noda K; Ukai Y
    Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterases as therapeutic targets for Alzheimer's disease.
    García-Osta A; Cuadrado-Tejedor M; García-Barroso C; Oyarzábal J; Franco R
    ACS Chem Neurosci; 2012 Nov; 3(11):832-44. PubMed ID: 23173065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells.
    O'Grady SM; Jiang X; Maniak PJ; Birmachu W; Scribner LR; Bulbulian B; Gullikson GW
    J Membr Biol; 2002 Jan; 185(2):137-44. PubMed ID: 11891572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
    Reyes-Irisarri E; Markerink-Van Ittersum M; Mengod G; de Vente J
    Eur J Neurosci; 2007 Jun; 25(11):3332-8. PubMed ID: 17553001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease.
    Wu Y; Li Z; Huang YY; Wu D; Luo HB
    J Med Chem; 2018 Jul; 61(13):5467-5483. PubMed ID: 29363967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes.
    Keravis T; Komas N; Lugnier C
    J Vasc Res; 2000; 37(4):235-49. PubMed ID: 10965223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer's Disease.
    Jankowska A; Wesołowska A; Pawłowski M; Chłoń-Rzepa G
    Curr Med Chem; 2020; 27(32):5351-5373. PubMed ID: 31250747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.
    Gantner F; Götz C; Gekeler V; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1998 Mar; 123(6):1031-8. PubMed ID: 9559883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of IP3/Ca
    Jyoti Dutta B; Singh S; Seksaria S; Das Gupta G; Bodakhe SH; Singh A
    Biochem Pharmacol; 2022 Jul; 201():115071. PubMed ID: 35525328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of phosphodiesterase isozymes in osteoblastic differentiation.
    Wakabayashi S; Tsutsumimoto T; Kawasaki S; Kinoshita T; Horiuchi H; Takaoka K
    J Bone Miner Res; 2002 Feb; 17(2):249-56. PubMed ID: 11811555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats.
    Reneerkens OA; Sambeth A; Blokland A; Prickaerts J
    Behav Brain Res; 2013 Aug; 250():251-6. PubMed ID: 23688598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.